Biopharma Co. Didn't Lie About Cancer Drug Progress: Judge
A California federal judge on Monday dismissed a proposed shareholder class action accusing experimental drug developer Vical Inc. of misleading investors about its cancer drug, describing the complaint as an attempt...To view the full article, register now.
Already a subscriber? Click here to view full article